Supernus Pharmaceuticals (SUPN) Q2 2019 Earnings

7MayConfirmed
Q3 2018
Q4 2018
Q1 2019
Q2 2019
0.27
0.37
0.47
0.57

Details

Expected EPS
0.48
Actual EPS
0.34
Surprise EPS
-0.14
Surprise Percent
+29.17%

Description

Supernus Pharmaceuticals (SUPN) has reported earnings of 0.34 per share for Q2 2019.

0 Comments

Share your thoughts